- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 41/00 - Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
Patent holdings for IPC class A61P 41/00
Total number of patents in this class: 489
10-year publication summary
|
24
|
24
|
15
|
28
|
37
|
53
|
35
|
43
|
23
|
7
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| ARC Medical Devices, Inc. | 22 |
12 |
| Omrix Biopharmaceuticals Ltd. | 159 |
7 |
| Kyoto University | 2732 |
6 |
| Novartis AG | 11238 |
5 |
| Toray Industries, Inc. | 6652 |
5 |
| Bioregen Biomedical (Changzhou) Co., Ltd. | 28 |
5 |
| Nanotheta Co, Ltd. | 27 |
5 |
| Xigen Inflammation Ltd. | 33 |
5 |
| Terumo Kabushiki Kaisha | 5216 |
4 |
| CoDa Therapeutics, Inc. | 19 |
4 |
| The Governing Council of The University of Toronto, | 1361 |
4 |
| Leading BioSciences Inc. | 13 |
4 |
| Mitsubishi Tanabe Pharma Corporation | 579 |
4 |
| Mochida Pharmaceutical Co., Ltd. | 334 |
4 |
| The University of Tokyo | 3903 |
4 |
| The Regents of the University of California | 18943 |
3 |
| Medtronic, Inc. | 9964 |
3 |
| The Board of Trustees of the Leland Stanford Junior University | 6054 |
3 |
| Battelle Memorial Institute | 2356 |
3 |
| Asahi Kasei Pharma Corporation | 144 |
3 |
| Other owners | 396 |